Citation Impact
Citing Papers
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: A review
2009
TEER Measurement Techniques for In Vitro Barrier Model Systems
2015 Standout
Depression
2018 Standout
A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies
2016 Standout
Safety classification of herbal medicines used in pregnancy in a multinational study
2016
Management of RA medications in pregnant patients
2009
Maternal fever during early pregnancy and the risk of oral clefts
2010
Rheumatoid arthritis
2016 Standout
Pregnancy and spinal problems
2010
In vitro simulation of placental transport: Part I. Biological model of the placental barrier
2013
Isotretinoin Use and the Risk of Inflammatory Bowel Disease: A Case–Control Study
2010
A systematic review of the global prevalence of low back pain
2012 Standout
Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small‐for‐gestational‐age newborns
2010
The use of isotretinoin in acne
2009
Cleft lip and palate: understanding genetic and environmental influences
2011 Standout
Acne vulgaris
2011 Standout
Congenital Heart Disease Associated With Selective Serotonin Reuptake Inhibitor Use During Pregnancy
2009
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Rheumatoid arthritis
2010 Standout
Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat
2010
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
Review: Problems associated with long-term treatment with selective serotonin reuptake inhibitors
2008
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
2015 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Herbal Products in Pregnancy: Experimental Studies and Clinical Reports
2014
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Antioxidant, Antimicrobial and Antiviral Properties of Herbal Materials
2020 Standout
Works of Driss Oraichi being referenced
Health care providers’ requests to Teratogen Information Services on medication use during pregnancy and lactation
2009
Duration of antidepressant use during pregnancy and risk of major congenital malformations
2008
Herbal products use during pregnancy: prevalence and predictors
2009
First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage
2006
Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern?
2006
Risk of congenital anomalies in pregnant users of non‐steroidal anti‐inflammatory drugs: a nested case‐control study
2006
Isotretinoin therapy and the incidence of acne relapse: a nested case–control study
2007
Prevalence and predictors of antidepressant use in a cohort of pregnant women
2007